Alison Jane Canty

Introduction: Programmed axon degeneration significantly affects neural connectivity, however, the underlying mechanisms remain poorly understood, particularly in cortical regions. Sterile Alpha and TIR motif-containing protein 1 (SARM1) is a known regulator of axon degeneration in the peripheral nervous system, but its role in cortical axon plasticity, particularly during injury conditions, remains unclear. This study examined the role of SARM1 in synaptic connectivity and remodelling in the adult sensory-motor cortex under normal physiological conditions and following acute axonal injury. Methods: Adult male Thy1-GFP-M mice (3–12 months) expressing EGFP in excitatory neurons were also either wild-type (WT-GFP) or null for SARM1 (SARM1KO-GFP). Using in vivo multiphoton microscopy, long cortical axon segments (~335 μm ± 140 μm), with terminaux and en passant synaptic boutons in the upper layers of the cortical neuropil, were repeatedly imaged at 48-h intervals to assess axon morphology, synaptic density, and synaptic turnover in the presence and absence of SARM1. Results: Without injury, axon morphology, synaptic density, and turnover were similar between WT and SARM1KO groups, suggesting that SARM1 is not necessary for maintaining baseline cortical synaptic connectivity. Following axotomy by laser lesion, the non-degenerating proximal axon (still connected to the soma) showed significant changes in synaptic plasticity, with an increased rate of loss of synapses. Discussion: Our findings suggest that SARM1 plays no role in the remodelling of synapses in the proximal axon after an acute axonal injury.

Background:Innovations in dementia policies and services are discussed and reported much less frequently in the dementia literature than innovations in clini... Background:Innovations in dementia policies and services are discussed and reported much less frequently in the dementia literature than innovations in clini...

Alzheimer’s disease (AD) is a terminal, neurodegenerative, dementia-causing disease characterized by progressive cognitive and behavioral decline. To date, there is no effective cure and limited treatment options for symptom management. Repetitive transcranial magnetic stimulation (rTMS) is a localized, noninvasive form of brain stimulation emerging as a potential therapeutic option for alleviating cognitive symptoms experienced in dementia-causing diseases such as AD.¹ However, individual response rates can be variable, and the underlying neural mechanisms of rTMS in AD have not yet been fully described.² In a healthy nervous system, biological consequences of rTMS are commonly linked to neuroplasticity-like mechanisms. In particular, rTMS delivered as intermittent theta burst stimulation (iTBS) is associated with an increase in neural excitability of stimulated cortical areas that outlasts the duration of the stimulation session,³ long-term neuroplastic cortical reorganization that underpins changes in learning and cognition,^{4 – 6} increase in functional brain connectivity,⁷ and synaptic facilitation at glutamatergic synapses via N-methyl-d-aspartate receptor activation and modulation of intracellular calcium signaling.^{8 – 10}

Background: The majority of individuals with Alzheimer’s disease (AD) exhibit vascular damage in the brain including reduced cerebral blood flow (CBF) and blood‐brain‐barrier (BBB) breakdown. Growing evidence suggests pericytes, a vessel‐residing cell able to modulate CBF and BBB integrity, are a major contributor to vascular dysfunction in AD. The close spatial relationship between microglia and capillaries led us to explore the hypothesis that microglia and pericytes functionally interact to influence vessel function in the healthy brain and that this interaction may become pathological in AD.Methods: We first characterized the spatial and functional relationship between microglia, capillaries and pericytes in the healthy central nervous system (CNS) in fixed tissue and using in vivo two‐photon microscopy through cranial windows in adult NG2DsRed x CX3CR1^+/GFP mice. We then assessed the spatial relationship between microglia, capillaries and pericytes in the human superior frontal gyrus (SFG) of 12 control and 11 AD cases.Results: We discovered a subset of microglia dynamically interacting with pericytes in the healthy CNS, which we termed pericyte‐associated microglia (PEM). PEM are present throughout the capillary tree, often maintain their position for at least 28 days and frequently were found to associate with pericytes lacking astroglial endfeet coverage. The loss of PEM alters capillary width beneath pericytes, but deletion of the microglial fractalkine receptor (CX3CR1), which regulates the recruitment of microglia to sites of neuroinflammation, does not reduce the proportion of microglia that are PEM. In AD, we found the proportion of microglia associated with capillaries and pericytes declines in the superior frontal gyrus (SFG) and that this decline is exacerbated by the APOE ε3/ε4 genotype. This reduction occurs despite an overall increase in pericyte numbers in AD cases.Conclusion: We identify microglia specifically associating with pericytes in the healthy CNS and find these associations are reduced in AD. The changing relationship between microglia, capillaries and pericytes may be a novel mechanism contributing to vascular dysfunction in AD.

Background: To hope is to be human, and it has been examined in diverse disciplinary perspectives across theology, philosophy and anthropology. However, hope is more than an idea. It has the potential to positively impact people across the life course, particularly those living with conditions like dementia. Hope can be meaningfully experienced at the individual, group and community levels through its potent power to build resilience. Despite this significance, there are sizeable gaps in our knowledge of the brain mechanisms underlying hope.Method: We explore how understanding hope as a neurobiological entity is an exciting prospect. As a possible key to tackling challenges of dementia, it could buoy the ability for patients and their families to cope with the devastation of diagnosis, as well as the sense of doom, anxiety, loss and despair that follows.Results: The literature suggests that hope may be situated in the frontal cortex, although more research in this area is needed. With an understanding of the neurobiological basis of hope, interventions focused on instilling hope to improve quality of life are needed urgently.Conclusion: If hope can be harnessed for brain health, both therapeutically and preventatively, it has the potential to be used as a ‘tool’ to improve patient and family experiences with dementia, as well as that of our greater society.

Background: Repetitive transcranial magnetic stimulation (rTMS) is non‐invasive brain stimulation with therapeutic potential for use in diseases causing dementia. We previously demonstrated that low intensity (LI) rTMS induced functional improvements in the accuracy and rate of learning in adult mouse skilled reaching paradigms (Tang, Bennett et al, Scientific Reports, 2018) and induced dendritic spine changes in cortical motor neurons after a single application of LI‐rTMS (Tang, Bennett et al, Brain Stimulation, 2021). Here, we investigate the effect of LI‐rTMS on axonal boutons of excitatory axons in the presence of amyloid pathology in the APP‐PS1 mouse.Method: APP/PS1 mice were crossed with Thy1‐GFPM mice to visualise excitatory axon circuitry in the presence of amyloid plaque pathology. Multiphoton imaging through a cranial window was used to identify cortical axons in the upper layers of the sensorimotor cortex in adult animals (10‐12 months old) and monitor the stability and turnover (gains and losses as a fraction of total number of synapses) of axonal boutons in the presence (APP‐GFPM) or absence (WT‐GFPM) of amyloid pathology. Axons were imaged at 48‐hour intervals for 8 days either side of a single session of LI‐rTMS.Result: The density of axonal boutons along the axon shaft was stable and comparable in APP‐GFPM and WT‐GFP mice, before and after LI‐rTMS. The turnover of synapses was significantly (p < 0.05) reduced in APP‐GFPM cortical axons compared to WT‐GFPM prior to stimulation. A single session of LI‐rTMS induced a significant (p < 0.01)and sustained increase in synaptic turnover in both genotypes. Interestingly the initial lower turnover of boutons in the APP‐GFPM cortex was increased to the levels observed in WT‐GFPM axons at baseline.Conclusion: In the presence of amyloid pathology, synaptic density in excitatory cortical axons is unchanged, however the dynamic fraction of synapses is reduced in compared to aged‐matched controls. LI‐rTMS boosts synaptic plasticity in mature cortical axons in both the presence and absence of plaque pathology. Together with our findings of improved functional performance following stimulation, these results suggest not only possible mechanisms of action but also a potential clinical benefit in the management of Alzheimer’s disease.

Cerebral blood flow (CBF) is important for the maintenance of brain function and its dysregulation has been implicated in Alzheimer's disease (AD). Microglia associations with capillaries suggest they may play a role in the regulation of CBF or the blood–brain‐barrier (BBB). We explored the relationship between microglia and pericytes, a vessel‐resident cell type that has a major role in the control of CBF and maintenance of the BBB, discovering a spatially distinct subset of microglia that closely associate with pericytes. We termed these pericyte‐associated microglia (PEM). PEM are present throughout the brain and spinal cord in NG2DsRed × CX₃CR1^+/GFP mice, and in the human frontal cortex. Using in vivo two‐photon microscopy, we found microglia residing adjacent to pericytes at all levels of the capillary tree and found they can maintain their position for at least 28 days. PEM can associate with pericytes lacking astroglial endfeet coverage and capillary vessel width is increased beneath pericytes with or without an associated PEM, but capillary width decreases if a pericyte loses a PEM. Deletion of the microglia fractalkine receptor (CX₃CR1) did not disrupt the association between pericytes and PEM. Finally, we found the proportion of microglia that are PEM declines in the superior frontal gyrus in AD. In summary, we identify microglia that specifically associate with pericytes and find these are reduced in number in AD, which may be a novel mechanism contributing to vascular dysfunction in neurodegenerative diseases.

Cerebral blood flow is important for the maintenance of brain function and its dysregulation has been implicated in Alzheimer’s disease (AD). Subpopulations of microglia have well-characterised associations with the vasculature in the central nervous system but the precise relationship between microglia and cells which exist on the vasculature is not yet clear. In this study we explored the relationship between microglia and pericytes, a vessel-resident cell type that has a major role in the regulation of cerebral blood flow and maintenance of the blood brain barrier. Using fixed tissue sections and in vivo live imaging, we discovered a subset of microglia that closely associated with pericytes, termed PE ricyte-associated M icroglia (PEM). PEM are present throughout all regions of the brain and spinal cord in NG2DsRed x CX ₃ CR1 ^+/GFP mice, and in the human frontal cortex. They reside adjacent to pericytes at all levels of the capillary tree and can maintain their position for at least 28 days. PEM associate with pericytes lacking astroglial endfeet coverage but are segregated from pericytes by capillary basement membranes and capillary vessel width is similarly increased beneath pericytes with or without an associated PEM. Deletion of the microglia fractalkine receptor (CX ₃ CR1) did not disrupt the association between pericytes and PEM, suggesting the association is not reliant on fractalkine signalling. Finally, we found that the proportion of microglia that are capillary-associated and PEM declines in the superior frontal gyrus (SFG) in AD, which is exacerbated by the APOE ε3/ε4 genotype. In summary, we identify and characterise a subpopulation of microglia that specifically associate with pericytes and find this population is reduced in the SFG in AD. This reduction may be a novel mechanism contributing to vascular dysfunction in diseases such as AD.